XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 04, 2026
Mar. 29, 2025
Operating Activities    
Net Income Attributable to Kadant $ 25,509 $ 24,063
Net income attributable to noncontrolling interests 312 374
Net Income 25,821 24,437
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,647 12,013
Stock-based compensation expense 2,916 2,757
Provision for (recovery of) losses on accounts receivable 272 (240)
Other items, net 3,509 2,337
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable (14,323) (1,068)
Contract assets 697 6,310
Inventories (9,214) (5,516)
Other assets (1,635) (1,368)
Accounts payable 2,522 (1,658)
Customer deposits 7,308 (827)
Other liabilities (10,604) (14,342)
Net cash provided by operating activities 21,916 22,835
Investing Activities    
Acquisition holdback payment (Note 2) (1,157) 0
Purchases of property, plant, and equipment (3,258) (3,836)
Proceeds from sale of property, plant, and equipment 489 0
Net cash used in investing activities (3,926) (3,836)
Financing Activities    
Proceeds from issuance of long-term obligations 9,000 8,000
Repayment of short- and long-term obligations (19,129) (22,563)
Tax withholding payments related to stock-based compensation (4,923) (6,036)
Dividends paid (4,008) (3,762)
Proceeds from issuance of Company common stock 0 2,101
Dividends paid to noncontrolling interests (990) (825)
Net cash used in financing activities (20,050) (23,085)
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash (804) 1,945
Decrease in Cash, Cash Equivalents, and Restricted Cash (2,864) (2,141)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 122,681 95,946
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 119,817 $ 93,805